Reverse Transcription Polymerase Chain Reaction (RT-PCR) Kits Market Global Report 2026

The reverse transcription polymerase chain reaction (RT-PCR) kits market size has grown strongly in recent years. It will grow from $5.36 billion in 2025 to $5.83 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to rising prevalence of respiratory infectious diseases, increased utilization of RT-PCR in clinical diagnostics, growing investment in molecular biology research, expansion of diagnostic laboratory infrastructure, and widespread adoption of COVID-19 testing programs.

The reverse transcription polymerase chain reaction (RT-PCR) kits market size is expected to see strong growth in the next few years. It will grow to $8.19 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth during the forecast period can be attributed to rising demand for multiplex pathogen detection technologies, increasing adoption of digital PCR platforms, growing emphasis on personalized and precision medicine applications, expansion of decentralized and point-of-care molecular diagnostics, and continuous advancement of automated high-throughput diagnostic systems. Major trends expected in the forecast period include broader use of multiplex RT-PCR assays for simultaneous pathogen identification, increasing demand for rapid molecular diagnostic turnaround times, development of high-sensitivity RT-PCR kits with lower detection thresholds, expansion of portable and point-of-care RT-PCR solutions, and stronger focus on automation and simplified diagnostic workflows in molecular testing.

The increasing incidence of infectious diseases is expected to drive the growth of the reverse transcription polymerase chain reaction (RT-PCR) kits market going forward. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can invade the body and disrupt normal physiological functions. The rising occurrence of infectious diseases is primarily driven by increasing global population movement and urbanization, which accelerate the transmission of viruses and bacterial infections across regions. Reverse transcription polymerase chain reaction (RT-PCR) kits are used in infectious disease diagnostics to detect and identify RNA-based pathogens, such as viruses, through rapid and accurate amplification of viral genetic material. For instance, in March 2025, according to the UK Health Security Agency, a UK-based agency responsible for all health security, tuberculosis (TB) cases rose by 11% in 2023 compared to 2022, while preliminary data for 2024 indicated an additional 13% increase, resulting in over 600 more reported TB diagnoses in 2024 than in 2023. Therefore, the rising incidence of infectious diseases is driving the growth of the reverse transcription polymerase chain reaction (RT-PCR) kits market.

Key companies operating in the reverse transcription polymerase chain reaction (RT-PCR) kits market are focusing on developing advanced molecular diagnostic solutions, such as high-performance RT-qPCR kits, to improve testing accuracy, sensitivity, and workflow efficiency. High-performance RT-qPCR kits refer to advanced molecular testing solutions designed to deliver rapid, precise, and reliable RNA detection for research and diagnostic applications. For example, in April 2026, Watchmaker Genomics, a US-based biotechnology company, launched Stellar RT-qPCR and qPCR Kits to support robust assay development and molecular testing workflows. The kits are designed to provide enhanced sensitivity, reproducibility, and inhibitor tolerance, helping researchers and diagnostic laboratories achieve accurate results in gene expression analysis and infectious disease detection.

In April 2026, QuidelOrtho Corporation, a US-based pure-play diagnostics company, acquired LEX Diagnostics Limited for $100 million. Through this acquisition, QuidelOrtho strengthened its molecular diagnostics portfolio by obtaining access to LEX Diagnostics’ rapid PCR technology platform, including the ultra-fast VELO system capable of generating RT-PCR results within minutes. LEX Diagnostics is a UK-based molecular diagnostics company specializing in ultra-fast RT-PCR testing platforms for infectious disease detection.

Major companies operating in the reverse transcription polymerase chain reaction (RT-PCR) kits market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Siemens Healthineers AG, Merck KGaA, Becton Dickinson and Company, Hologic Inc., Eurofins Scientific SE, bioMérieux SA, Agilent Technologies Inc., Revvity Inc., QIAGEN N.V., Bio-Rad Laboratories Inc., LGC Biosearch Technologies, Luminex Corporation, GenScript Biotech Corporation, Takara Bio Inc., Promega Corporation, Seegene Inc., New England Biolabs Inc., Sansure Biotech Inc., Tata Medical and Diagnostics Limited, Molbio Diagnostics Private Limited, Zymo Research Corporation.

North America was the dominant region in the reverse transcription polymerase chain reaction (RT-PCR) kits market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in reverse transcription polymerase chain reaction (RT-PCR) kits report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the reverse transcription polymerase chain reaction (RT-PCR) kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The reverse transcription polymerase chain reaction (RT-PCR) kits market includes revenues earned by entities by providing serivces such as diagnostic testing services, laboratory analysis services, infectious disease screening services, and molecular testing support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The reverse transcription polymerase chain reaction (RT-PCR) kits market also includes sales of RT-PCR assay kits, reagent kits, primers and probes, enzymes, nucleic acid extraction kits, control samples, and related molecular diagnostic consumables used for RNA detection and infectious disease testing. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The reverse transcription polymerase chain reaction (RT-PCR) kits market research report is one of a series of new reports that provides reverse transcription polymerase chain reaction (RT-PCR) kits market statistics, including reverse transcription polymerase chain reaction (RT-PCR) kits industry global market size, regional shares, competitors with a reverse transcription polymerase chain reaction (RT-PCR) kits market share, detailed reverse transcription polymerase chain reaction (RT-PCR) kits market segments, market trends and opportunities, and any further data you may need to thrive in the reverse transcription polymerase chain reaction (RT-PCR) kits industry. This reverse transcription polymerase chain reaction (RT-PCR) kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.